Analysis of the tangled relationships between P-glycoprotein-mediated multidrug resistance and the lipid phase of the cell membrane

European Journal of Biochemistry

Volumn 267, Issue 2, 2000, Pages 277-294

  Ferté, Jacques ^a  

^a CEA SACLAY   (France)

Author keywords

Drug membrane interactions; Membrane lipids; Multidrug resistance; P glycoprotein; Protein lipid interactions

Indexed keywords

ALDOSTERONE; COLCHICINE; CYCLOSPORIN A; DOXORUBICIN; GLYCOPROTEIN P; GRAMICIDIN D; HOE 33342; MEMBRANE LIPID; MEMBRANE PROTEIN; NICARDIPINE; PACLITAXEL; POLYSORBATE 80; PROGESTERONE; RHODAMINE 123; SOLUTOL HS 15; TAMOXIFEN; TRIFLUOPERAZINE; TRITON X 100; VALINOMYCIN; VALSPODAR; VERAPAMIL; VINBLASTINE;

CELL MEMBRANE; DRUG BINDING; LIPID METABOLISM; LIPID TRANSPORT; MULTIDRUG RESISTANCE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN LIPID INTERACTION; REVIEW;

ANIMALS; BINDING SITES; BIOLOGICAL TRANSPORT; CELL MEMBRANE; DRUG RESISTANCE, MULTIPLE; HUMANS; MEMBRANE LIPIDS; P-GLYCOPROTEINS; PHARMACEUTICAL PREPARATIONS;

EID: 0033969525     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1327.2000.01046.x     Document Type: Review

References (258)

1. 1. Biedler, J.L. & Riehm, H. (1970) Cellular resistance to actinomycin D in Chinese hamster cells in vitro: cross resistance, autoradiographic, and cytogenetic studies. Cancer Res. 30, 1174-1184.
2. 2. Nielsen, D., Maare, C. & Skovsgaard, T. (1996) Cellular resistance to anthracyclines. Gen. Pharmacol. 27, 251-255.
3. 3. Carlsen, S.A., Till, J.E. & Ling, V. (1976) Modulation of membrane drug permeability in Chinese hamster ovary cells. Biochim. Biophys. Acta 455, 900-912.
4. 4. Higgins, C.F. (1992) ABC transporters: from microorganisms to man. Annu. Rev. Cell. Biol. 8, 67-113.
5. 5. Doige, C.A. & Ames, G.F. (1993) ATP-dependent transport systems in bacteria and humans: relevance to cystic fibrosis and multidrug resistance. Annu. Rev. Microbiol. 47, 291-319.
6. 6. Gottesman, M.M., Hrycyna, C.A., Schoenlein, P.V., Germann, U.A. & Pastan, I. (1995) Genetic analysis of the multidrug transporter. Annu. Rev. Genet. 29, 607-649.
7. 7. Leveille-Webster, C.R. & Arias, I.M. (1995) The biology of P-glycoproteins. J. Membr. Biol. 143, 89-102.
8. 8. Germann, U.A. (1996) P-glycoprotein - a mediator of multidrug resistance in tumour cells. Eur. J. Cancer 32A, 927-944.
9. 9. Ambudkar, S.V., Dey, S., Hrycyna, C.A., Ramachandra, M., Pastan, I. & Gottesman, M.M. (1999) Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu. Rev. Pharmacol. Toxicol. 39, 361-398.
10. 10. Wadkins, R.M. & Roepe, P.D. (1997) Biophysical aspects of P-glycoprotein-mediated multidrug resistance. Int. Rev. Cytol. 171, 121-165.
11. 11. Sharom, F.J. (1997) The P-glycoprotein efflux pump: how does it transport drugs? J. Membr. Biol. 160, 161-175.
12. 12. Ford, J.M. & Hait, W.N. (1990) Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacol. Rev. 42, 155-199.
13. 13. Beck, W.T. & Qian, X. (1992) Photoaffinity substrates for P-glycoprotein. Biochem. Pharmacol. 43, 89-93.
14. 14. Boer, R., Dichtl, M., Borchers, C., Ulrich, W.R., Marecek, J.F., Prestwich, G.D., Glossmann, H. & Striessnig, J. (1996) Reversible labeling of a chemosensitizer binding domain of P-glycoprotein with a novel 1,4-dihydropyridine drug transport inhibitor. Biochemistry 35, 1387-1396.
15. 15. Liu, R. & Sharom, F.J. (1996) Site-directed fluorescence labeling of P-glycoprotein on cysteine residues in the nucleotide binding domains. Biochemistry 35, 11865-11873.
16. 16. Dayan, G., Jault, J.M., Baubichon-Cortay, H., Baggetto, L.G., Renoir, J.M., Baulieu, E.E., Gros, P. & Di Pietro, A. (1997) Binding of steroid modulators to recombinant cytosolic domain from mouse P-glycoprotein in close proximity to the ATP site. Biochemistry 36, 15208-15215.
17. 17. Sonveaux, N., Shapiro, A.B., Goormaghtigh, E., Ling, V. & Ruysschaert, J.M. (1996) Secondary and tertiary structure changes of reconstituted P-glycoprotein - a Fourier transform attenuated total reflection infrared spectroscopy analysis. J. Biol. Chem. 271, 24617-24624.
18. 18. Mechetner, E.B., Schott, B., Morse, B.S., Stein, W.D., Druley, T., Davis, K.A., Tsuruo, T. & Roninson, I.B. (1997) P-glycoprotein function involves conformational transitions detectable by differential immunoreactivity. Proc. Natl Acad. Sci. USA 94, 12908-12913.
19. 19. Wang, G., Pincheira, R., Zhang, M. & Zhang, J.T. (1997) Conformational changes of P-glycoprotein by nucleotide binding. Biochem. J. 328, 897-904.
20. 20. Wang, G., Pincheira, R. & Zhang, J.T. (1998) Dissection of drug-binding-induced conformational changes in P-glycoprotein. Eur. J. Biochem. 255, 383-390.
21. 21. Loo, T.W. & Clarke, D.M. (1997) Correction of defective protein kinesis of human P-glycoprotein mutants by substrates and modulators. J. Biol. Chem. 272, 709-712.
22. 22. Scala, S., Akhmed, N., Rao, U.S., Paull, K., Lan, L.B., Dickstein, B., Lee, J.S., Elgemeie, G.H., Stein, W.D. & Bates, S.B. (1997) P-glycoprotein substrates and antagonists cluster into two distinct groups. Mol. Pharmacol. 51, 1024-1033.
23. 23. Litman, T., Zeuthen, T., Skovsgaard, T. & Stein, W.D. (1997) Structure-activity relationships of P-glycoprotein interacting drugs: kinetic characterization of their effects on ATPase activity. Biochim. Biophys. Acta 1361, 159-168.
24. 24. Gottesman, M.M., Pastan, I. & Ambudkar, S.V. (1996) P-glycoprotein and multidrug resistance. Curr. Opin. Genet. Devel. 6, 610-617.
25. 25. Yusa, K., Naito, M. & Tsuruo, T. (1996) Transport of P-glycoprotein-modifying agents by P-glycoprotein. In Multidrug Resistance in Cancer Cells - Molecular, Biochemical, Physiological and Biological Aspects (Gupta, S., Tsuruo, T., eds), pp. 331-343. John Wiley & Sons, New York.
26. 26. Speelmans, G., Staffhorst, R.W.H.M., de Kruijff, B. & de Wolf, F.A. (1994) Transport studies of doxorubicin in model membranes indicate a difference in passive diffusion across and binding at the outer and inner leaflets of the plasma membrane. Biochemistry 33, 13761-13768.
27. 27. Bäuerle, H.D. & Seelig, J. (1991) Interaction of charged and uncharged calcium channel antagonists with phospholipid membranes. Binding equilibrium, binding enthalpy, and membrane location. Biochemistry 30, 7203-7211.
28. 28. Jørgensen, K., Ipsen, J.H., Mouritsen, O.G., Bennett, D. & Zuckermann, M.J. (1991) A general model for the interaction of foreign molecules with lipid membranes: drugs and anaesthetics. Biochim. Biophys. Acta 1062, 227-238.
29. 29. Wimley, W.C. & White, S.H. (1993) Membrane partitioning: distinguishing bilayer effects from the hydrophobic effects. Biochemistry 32, 6307-6312.
30. 30. Mason, R.P., Rhodes, D.G. & Herberte, L.G. (1991) Reevaluating equilibrium and kinetic binding parameters for lipophilic drugs based on a structural model for drug interaction with biological membranes. J. Med. Chem. 34, 869-877.
31. 31. Seydel, J.K., Coats, E.A., Cordes, H.P. & Wiese, M. (1994) Drug membrane interactions and their importance for drug transport, distribution, accumulation, efficacy and resistance. Arch. Pharm. 327, 601-610.
32. 32. Eytan, G.D., Regev, R., Oren, G. & Assaraf, Y.G. (1996) The role of passive transbilayer drug movement in multidrug resistance and its modulation. J. Biol. Chem. 271, 12897-12902.
33. 33. Austin, R.P., Davis, A.M. & Mannes, C.N. (1995) Partitioning of ionized molecules between aqueous buffers and phospholipid vesicles. J. Pharm. Sci. 84, 1180-1183.
34. 34. Avdeef, A., Box, K.J., Comer, J.E.A., Hibbert, C. & Tam, K.Y. (1998) pH-metric logP 10. Determination of liposomal membrane-water partition coefficients of ionizable drugs. Pharm. Res. 15, 209-215.
35. 35. Krämer, S.D., Braun, A., Jakits-Deiser, C. & Wunderli-Allenspach, H. (1998) Towards the predictability of drug-lipid membrane interactions: the pH-dependent affinity of propranolol to phosphatidylinositol containing liposomes. Pharm. Res. 15, 739-744.
36. 36. Limbacher, H.P. Jr, Blickenstaff, G.D., Bowen, J.H. & Wang, H.H. (1985) Multiequilibrium binding of a spin-labeled local anesthetic in phosphatidylcholine bilayers. Biochim. Biophys. Acta 812, 268-276.
37. 37. Goormaghtigh, E., Chatelain, P., Caspers, J. & Ruysschaert, J.M. (1980) Evidence of a specific complex between adriamycin and negatively-charged phospholipids. Biochim. Biophys. Acta 597, 1-14.
38. 38. Tritton, T.R. (1991) Cell surface actions of adriamycin. Pharmacol. Ther. 49, 293-309.
39. 39. Bae, S.J., Kitamura, S., Herbette, L.G. & Sturtevant, J.M. (1989) The effects of calcium channel blocking drugs on the thermotropic behavior of dimyristoylphosphatidylcholine. Chem. Phys. Lipids 51, 1-7.
40. 40. Luxnat, M. & Galla, H.J. (1986) Partition of chlorpromazine into lipid bilayer membranes: the effect of membrane structure and composition. Biochim. Biophys. Acta 856, 274-282.
41. 41. Seelig, A., Allegrini, P.R. & Seelig, J. (1988) Partitioning of local anesthetics into membranes: surface charge effects monitored by the phospholipid head-group. Biochim. Biophys. Acta 939, 267-276.
42. 42. Pohl, E.E., Krylov, A.V., Block, M. & Pohl, P. (1998) Changes of the membrane potential profile induced by verapamil and propranolol. Biochim. Biophys. Acta 1373, 170-178.
43. 2+ channel blockers to the membrane lipid bilayer. Mol. Pharmacol. 41, 315-321.
44. 31P NMR studies on the interaction of some phenothiazine derivatives with dipalmitoyl phosphatidylcholine model membranes. Biochim. Biophys. Acta 507, 185-197.
45. 45. Fernández, M.S. & Fromherz, P. (1977) Lipoid pH indicators as probes of electrical potential and polarity in micelles. J. Phys. Chem. 81, 1755-1761.
46. 46. Flewelling, R.F. & Hubbell, W.L. (1986) The membrane dipole potential in a total membrane potential model. Applications to hydrophobic ion interactions with membranes. Biophys. J. 49, 541-552.
47. 47. Franklin, J.C., Cafiso, D.S., Flewelling, R.F. & Hubbell, W.L. (1993) Probes of membrane electrostatics: synthesis and voltage-dependent partitioning of negative hydrophobic ion spin labels in lipid vesicles. Biophys. J. 64, 642-653.
48. 48. Schinkel, A.H., Wagenaar, E., Mol, C.A.A.M. & Van Deemter, L. (1996) P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. J. Clin. Invest. 97, 2517-2524.
49. 49. Seelig, A. (1998) A general pattern for substrate recognition by P-glycoprotein. Eur. J. Biochem. 251, 252-261.
50. 50. Fischer, H., Gottschlich, R. & Seelig, A. (1998) Blood-brain barrier permeation: molecular parameters governing passive diffusion. J. Membr. Biol. 165, 201-211.
51. 51. Pidgeon, C., Ong, S., Liu, H., Qiu, X., Pidgeon, M., Dantzig, A.H., Munroe, J., Hornback, W.J., Kasher, J.S., Glunz, L. & Szeerba, T. (1995) IAM chromatography: an in vitro screen for predicting drug membrane permeability. J. Med. Chem. 38, 590-594.
52. 52. Yang, Q., Liu, X.Y., Umetani, K., Kamo, N. & Miyake, J. (1999) Partitioning of triphenylalkylphosphonium homologues in gel bead-immobilized liposomes: Chromatographic measurement of their membrane partition coefficients. Biochim. Biophys. Acta 1417, 122-130.
53. 53. Higgins, C.F. (1994) Flip-flop: the transmembrane translocation of lipids. Cell 79, 393-395.
54. 54. Heywang, C. & Saint-Pierre Chazalet, M., Masson, M. & Bolard, J. (1998) Orientation of anthracyclines in lipid monolayers and planar asymmetrical bilayers: a surface-enhanced resonance Raman scattering study. Biophys. J. 75, 2368-2381.
55. 55. James, A.D., Robinson, B.H. & White, N.C. (1977) Dynamics of small molecule-micelle interactions: charge and pH effects on the kinetics of the interaction of dyes with micelles. J. Colloid Interface Sci. 59, 328-336.
56. 56. Frézard, F. & Garnier-Suillerot, A. (1991) Comparison of the membrane transport of anthracyclines derivatives in drug-resistant and drug-sensitive K562 cells. Eur. J. Biochem. 196, 483-491.
57. 57. Webb, M.S., Wheeler, J.J., Bally, M.B. & Mayer, L.D. (1995) The cationic lipid stearylamine reduces the permeability of the cationic drugs verapamil and prochlorperazine to lipid bilayers: implications for drug delivery. Biochim. Biophys. Acta 1238, 147-155.
58. 58. Mankhetkorn, S. & Garnier-Suillerot, A.G. (1998) The ability of verapamil to restore intracellular accumulation of anthracyclines in multidrug resistant cells depends on the kinetics of their uptake. Eur. J. Pharmacol. 343, 313-321.
59. 59. Regev, R. & Eytan, G.D. (1997) Flip-flop of doxorubicin across erythrocyte and lipid membranes. Biochem. Pharmacol. 54, 1151-1158.
60. 60. Mayer, L.D., Bally, M.B. & Cullis, P.R. (1986) Uptake of adriamycin into large unilamellar vesicles in response to a pH gradient. Biochim. Biophys. Acta 857, 123-126.
61. 61. Cullis, P.R., Hope, M.J., Bally, M.B., Madden, T.D., Mayer, L.D. & Fenske, D.B. (1997) Influence of pH gradients on the transbilayer transport of drugs, lipids, peptides and metal ions into large unilamellar vesicles. Biochim. Biophys. Acta 1331, 187-211.
62. 62. Madden, T.D. & Redelmeier, T.E. (1994) Transmembrane distribution of lipophilic cations in response to an electrochemical potential in reconstituted cytochrome c oxidase vesicles and in vesicles exhibiting a potassium ion diffusion potential. J. Bioenerg. Biomembr. 26, 221-230.
63. 63. Ramu, A. & Ramu, N. (1994) Reversal of multidrug resistance by bis (phenylalkyl) amines and structurally related compounds. Cancer Chemother. Pharmacol. 34, 423-430.
64. 64. Kirk, J., Syed, S.K., Harris, A.L., Jarman, M., Roufogalis, B.D., Stratford, I.J. & Carmichael, J. (1994) Reversal of P-glycoprotein-mediated multidrug resistance by pure anti-oestrogens and novel tamoxifen derivatives. Biochem. Pharmacol. 48, 277-285.
65. 65. Boer, R., Ulrich, W.R., Haas, S., Borches, C., Gekeler, V., Boss, H., Przybylski, M. & Schödl, A. (1996) Interaction of cytostatics and chemosensitizers with the dexniguldipine binding site on P-glycoprotein. Eur. J. Pharmacol. 295, 253-260.
66. 66. Ferte, J., Kühnel, J.M., Chapuis, G., Rolland, Y., Lewin, G. & Schwaller, M.A. (1999) Flavonoid-related modulators of multidrug resistance: synthesis, pharmacological activity, and structure-activity relationships. J. Med. Chem. 42, 478-489.
67. 67. Müller, M., Mayer, R., Hero, U. & Keppler, D. (1994) ATP-dependent transport of amphiphilic cations across the hepatocyte canalicular membrane mediated by mdrl P-glycoprotein. FEBS Lett. 343, 168-172.
68. 68. Strichartz, G. (1976) Molecular mechanisms of nerve block by local anesthetics. Anesthesiology 45, 421-441.
69. 69. Aracava, Y., Ikeda, S.R., Daly, J.W., Brookes, N. & Albuquerque, E.X. (1984) Interactions of bupivacaine with ionic channels of the nicotinic receptor. Analysis of single-channel currents. Mol. Pharmacol. 26, 304-313.
70. 70. Stole, S., Nemcek, V. & Szocsova, H. (1989) Local anesthetics: lipophilicity, charge, diffusion and site of action in isolated neuron. Eur. J. Pharmacol. 164, 249-256.
71. 71. Eytan, G.D., Regev, R., Oren, G., Hurwitz, C.D. & Assaraf, Y.G. (1997) Efficiency of P-glycoprotein-mediated exclusion of rhodamine dyes from multidrug-resistant cells is determined by their passive transmembrane movement rate. Eur. J. Biochem. 248, 104-112.
72. 72. Mülder, H.S., Dekker, H., Pinedo, H.M. & Lankelma, J. (1995) The P-glycoprotein-mediated relative decrease in cytosolic free drug concentration is similar for several anthracyclines with varying lipophilicity. Biochem. Pharmacol. 50, 967-974.
73. 73. Lampidis, T.J., Kolonias, D., Podona, T., Israel, M., Safa, A.R., Lothstein, L., Savaraj, N., Tapiero, H. & Priebe, W. (1997) Circumvention of P-gp MDR as a function of anthracycline lipophilicity and charge. Biochemistry 36, 2679-2685.
74. 74. Borrel, M.N., Fiallo, M., Veress, I. & Garnier-Suillerot, A. (1995) The effect of crown ethers, tetraalkylammonium salts, and polyoxyethylene amphiphiles on pirarubicin incorporation in K562 resistant cells. Biochem. Pharmacol. 50, 2069-2076.
75. 75. Mankhetkorn, S., Dubru, F., Hesschenbrouck, J., Fiallo, M. & Garnier-Suillerot, A. (1996) Relation among the resistance factor, kinetics of uptake, and kinetics of the P-glycoprotein-mediated efflux of doxorubicin, daunorubicin, 8-(S)-fluoroidarubicin, and idarubicin in multidrug-resistant K562 cells. Mol. Pharmacol. 49, 532-539.
76. 76. Barnes, K.M., Dickstein, B., Cutler, G.B., Jr, Fojo, T. & Bates, S.E. (1996) Steroid transport, accumulation, and antagonism of P-glycoprotein in multidrug-resistant cells. Biochemistry 35, 4820-4827.
77. 77. Borgnia, M.J., Eytan, G.D. & Assaraf, Y.G. (1996) Competition of hydrophobic peptides, cytotoxic drugs, and chemosensitizers on a common P-glycoprotein pharmacophore as revealed by its ATPase activity. J. Biol. Chem. 271, 3163-3171.
78. 78. Klopman, G., Shi, L.M. & Ramu, A. (1997) Quantitative structure-activity relationship of multidrug resistance reversal agents. Mol. Pharmacol. 52, 323-334.
79. 79. Tanaka, K., Hirai, M., Tanigawara, Y., Yasuhara, M., Hori, R., Ueda, K. & Inui, K. (1996) Effect of cyclosporin analogues and FK506 on transcellular transport of daunorubicin and vinblastine via P-glycoprotein. Pharm. Res. 13, 1073-1077.
80. 80. Sarkadi, B., Muller, M., Homolya, L., Hollo, Z., Seprodi, J., Germann, U.A., Gottesman, M.M., Price, E.M. & Boucher, R.C. (1994) Interaction of bioactive hydrophobic peptides with the human multidrug transporter. FASEB J. 8, 766-770.
81. 81. Friche, E., Buhl Jensen, P., Roed, H., Skovsgaard, T. & Nissen, N.I. (1990) In vitro circumvention of anthracycline-resistance in Ehrlich ascites tumour by anthracycline analogues. Biochem. Pharmacol. 39, 1721-1726.
82. 82. Chiba, P., Ecker, P., Schmid, D., Drach, J., Tell, B., Goldenberg, S. & Gekeler, V. (1996) Structural requirements for activity of propafenone-type modulators in P-glycoprotein-mediated multidrug resistance. Mol. Pharmacol. 49, 1122-1130.
83. 83. Kessel, D., Beck, W.T., Kukuruga, D. & Schulz, V. (1991) Characterization of multidrug resistance by fluorescent dyes. Cancer Res. 51, 4665-4670.
84. 84. Ichikawa, M., Yoshimura, A., Sumizawa, T., Shudo, N., Kuwazuru, Y., Furukawa, T. & Akiyama, S. (1991) Interaction of organic chemicals with P-glycoprotein in the adrenal gland, kidney, and a multidrug-resistant KB cell line. J. Biol. Chem. 266, 903-908.
85. 85. Raviv, Y., Pollard, H.B., Bruggemann, E.P., Pastan, I. & Gottesman, M.M. (1990) Photosensitized labeling of a functional multidrug transporter in living drug-resistant tumor cells. J. Biol. Chem. 265, 3975-3980.
86. 86. Homolya, L., Hollo, Z., Germann, U.A., Pastan, I., Gottesman, M.M. & Sarkadi, B. (1993) Fluorescent cellular indicators are extruded by the multidrug resistance protein. J. Biol. Chem. 268, 21493-21496.
87. 87. Sirotnak, F.M., Yang, C.H., Mines, L.S., Oribe, E. & Biedler, J.L. (1986) Markedly altered membrane transport and intracellular binding of vincristine in multidrug-resistant Chinese hamster cells selected for resistance to Vinca alkaloids. J. Cell. Physiol. 126, 266-274.
88. 88. Ramu, A., Pollard, H.B. & Rosario, L.M. (1989) Doxorubicin resistance in P388 leukemia: evidence for reduced drug influx. Int. J. Cancer 44, 539-547.
89. 89. Stein, W.D., Cardarelli, C., Pastan, I. & Gottesman, M.M. (1994) Kinetic evidence suggesting that the multidrug transporter differentially handles influx and efflux of its substrates. Mol. Pharmacol. 45, 763-772.
90. 90. Nielsen, D., Maare, C. & Skovsgaard, T. (1995) Influx of daunorubicin in multidrug resistant Ehrlich ascites tumor cells: correlation to expression of P-glycoprotein and efflux. Influence of verapamil. Biochem. Pharmacol. 50, 443-450.
91. 91. Bornmann, W.G. & Roepe, P.D. (1994) Analysis of drug transport kinetics in multidrug-resistant cells using a novel coumarin-vinblastine compound. Biochemistry 33, 12665-12675.
92. 92. Shapiro, A.B., Corder, A.B. & Ling, V. (1997) P-glycoprotein-mediated Hoechst 33342 transport out of the lipid bilayer. Eur. J. Biochem. 250, 115-121.
93. 93. Shapiro, A.B. & Ling, V. (1997) Extraction of Hoechst 33342 from the cytoplasmic leaflet of the plasma membrane by P-glycoprotein. Eur. J. Biochem. 250, 122-129.
94. 94. Romsicki, Y. & Sharom, F.J. (1999) The membrane lipid environment modulates drug interactions with the P-glycoprotein multidrug transporter. Biochemistry 38, 6887-6896.
95. 95. Altenberg, G.A., Vanoye, C.G., Horton, J.K. & Reuss, L. (1994) Unidirectional fluxes of rhodamine 123 in multidrug-resistant cells: evidence against direct drug extrusion from the plasma membrane. Proc. Natl Acad. Sci. USA 91, 4654-4657.
96. 96. Seelig, A. (1987) Local anesthetics and pressure: a comparison of dibucaine binding to lipid monolayers and bilayers. Biochim. Biophys. Acta 899, 196-204.
97. 97. Schrier, S.L., Zachowski, A. & Devaux, P.F. (1992) Mechanisms of amphipath-induced stomatocytosis in human erythrocytes. Blood 79, 782-786.
98. 98. Sharom, F.J., Yu, X. & Doige, C.A. (1993) Functional reconstitution of drug transport and ATPase activity in proteoliposomes containing partially purified P-glycoprotein. J. Biol. Chem. 268, 24197-24202.
99. 99. Eytan, G.D., Borgnia, M.J., Regev, R. & Assaraf, Y.G. (1994) Transport of polypeptide ionophores into proteoliposomes reconstituted with rat liver P-glycoprotein. J. Biol. Chem. 269, 26058-26065.
100. 100. Shapiro, A.B. & Ling, V. (1998) Transport of LDS-751 from the cytoplasmic leaflet of the plasma membrane by the rhodamine-123-selective site of P-glycoprotein. Eur. J. Biochem. 254, 181-188.
101. 101. Eytan, G.D., Regev, R. & Assaraf, Y.G. (1996) Functional reconstitution of P-glycoprotein reveals an apparent near stoichiometric drug transport to ATP hydrolysis. J. Biol. Chem. 271, 3172-3178.
102. 102. Ambudkar, S.V., Cardarelli, C.O., Pashinsky, I. & Stein, W.D. (1997) Relation between the turnover number for vinblastine transport and for vinblastine-stimulated ATP hydrolysis by human P-glycoprotein. J. Biol. Chem. 272, 21160-21166.
103. 103. Shapiro, A.B. & Ling, V. (1998) Stoichiometiy of coupling of rhodamine 123 transport to ATP hydrolysis by P-glycoprotein. Eur. J. Biochem. 254, 189-193.
104. 104. Roepe, P.D. (1995) The role of the MDR protein in altered drug translocation across tumor cell membranes. Biochim. Biophys. Acta 1241, 385-406.
105. 105. Ayesh, S., Shao, Y.M. & Stein, W.D. (1996) Cooperative, competitive and non-competitive interactions between modulators of P-glycoprotein. Biochim. Biophys. Acta 1316, 8-18.
106. 106. Garrigos, M., Mir, L.M. & Orlowski, S. (1997) Competitive and non-competitive inhibition of the multidrug-resistance-associated P-glycoprotein ATPase - further experimental evidence for a multisite model. Eur. J. Biochem. 244, 664-673.
107. 107. Dey, S., Ramachandra, M., Pastan, I., Gottesman, M.M. & Ambudkar, S.V. (1997) Evidence for two nonidentical drug-interaction sites in the human P-glycoprotein. Proc. Natl Acad. Sci. USA 94, 10594-10599.
108. 108. Pascaud, C., Garrigos, M. & Orlowski, S. (1998) Multidrug resistance transporter P-glycoprotein has distinct but interacting binding sites for cytotoxic drugs and reversing agents. Biochem. J. 333, 351-358.
109. 109. Sharom, F.J., Yu, X., DiDiodato, G. & Chu, J.W. (1996) Synthetic hydrophobic peptides are substrates for P-glycoprotein and stimulate drug transport. Biochem. J. 320, 421-428.
110. 110. Shapiro, A.B., Fox, K., Lam, P. & Ling, V. (1999) Stimulation of P-glycoprotein-mediated drug transport by prazosin and progesterone. Evidence for a third drug-binding site. Eur. J. Biochem. 259, 841-850.
111. 111. Shapiro, A.B. & Ling, V. (1997) Positively cooperative sites for drug transport by P-glycoprotein with distinct drug specificities. Eur. J. Biochem. 250, 130-137.
112. 112. Orlowski, S., Mir, L.M., Belehradek, J. Jr & Garrigos, M. (1996) Effects of steroids and verapamil on P-glycoprotein ATPase activity: progesterone, desoxycorticosterone, corticosterone and verapamil are mutually non-exclusive modulators. Biochem. J. 317, 515-522.
113. 113. Sonveaux, N., Vigano, C., Shapiro, A.B., Ling, V. & Ruysschaert, J.M. (1999) Ligand-mediated tertiary structure changes of reconstituted P-glycoprotein. J. Biol. Chem. 274, 17649-17654.
114. 114. Gallois, L., Fiallo, M. & Garnier-Suillerot, A.G. (1998) Comparison of the interaction of doxorubicin, daunorubicin, idarubicin and idarubicinol with large unilamellar vesicles. Circular dichroism study. Biochim. Biophys. Acta 1370, 31-40.
115. 115. Ecker, G., Huber, M., Schmid, D. & Chiba, P. (1999) The importance of a nitrogen atom in modulators of multidrug resistance. Mol. Pharmacol. 56, 791-796.
116. 116. Vo, Q.D. & Gruol, D.J. (1999) Identification of P-glycoprotein mutations causing a loss of steroid recognition and transport. J. Biol. Chem. 274, 20318-20327.
117. 1H-NMR spectroscopies. Biophys. J. 71, 1191-1207.
118. 118. Pawagi, A.B., Wang, J., Silverman, M., Reithmeier, R.A.F. & Deber, C.M. (1994) Transmembrane aromatic amino acid distribution in P-glycoprotein. A functional role in broad substrate specificity. J. Mol. Biol. 235, 554-564.
119. 119. Zamora, J.M., Pearce, H.L. & Beck, W.T. (1988) Physical-chemical properties shared by compounds that modulate multidrug resistance in human leukemia cells. Mol. Pharmacol. 33, 454-465.
120. 120. Pearce, H.L., Winter, M.A. & Beck, W.T. (1990) Structural characteristics of compounds that modulate P-glycoprotein-associated multidrug resistance. Adv. Enzyme Reg. 30, 357-373.
121. 121. Selassie, C.D., Mansch, C. & Khwaja, T.A. (1990) Structure-activity relationships of antineoplasic agents in MDR. J. Med. Chem. 33, 1914-1919.
122. 122. Tang-Wai, D.F., Brossi, A., Arnold, L.D. & Gros, P. (1993) The nitrogen of the acetamido group of colchicine modulates P-glycoprotein-mediated multidrug resistance. Biochemistry 32, 6470-6476.
123. 123. Ramu, A. & Ramu, N. (1992) Reversal of multidrug resistance by phenothiazines and structurally related compounds. Cancer Chemother. Pharmacol. 30, 165-173.
124. 124. Klopman, G., Srivastava, S., Kolossvary, I., Epand, R.F., Ahmed, N. & Epand, R.M. (1992) Structure-activity study and design of multidrug-resistant reversal compounds by a computer automated structure evaluation methodology. Cancer Res. 52, 4121-4129.
125. 125. Suzuki, T., Fukazawa, N., San-Nobe, K., Sato, W., Yano, O. & Tsuruo, T. (1997) Structure-activity relationship of newly synthesized quinoline derivatives for reversal of multidrug resistance in cancer. J. Med. Chem. 40, 2047-2052.
126. 126. Pajeva, I.K., Wiese, M., Cordes, H.P. & Seydel, J.K. (1996) Membrane interactions of some catamphiphilic drugs and relation to their multidrug-resistance-reversing ability. J. Cancer Res. Clin. Oncol. 122, 27-40.
127. 127. Pajeva, I.K. & Wiese, M. (1997) QSAR and molecular modelling of catamphiphilic drugs able to modulate multidrug resistance in tumors. Quant. Struct. Act. Relat. 16, 1-10.
128. 128. Lawrence, D.K. & Gill, E.W. (1975) Structurally specific effects of some steroid anesthetics on spin-labeled liposomes. Mol. Pharmacol. 11, 280-286.
129. 129. Simon, S.M., Roy, D. & Schindler, M. (1994) Intracellular pH and the control of multidrug resistance. Proc. Natl Acad. Sci. USA 91, 1128-1132.
130. 130. Roepe, P.D. (1998) The P-glycoprotein efflux pump: how does it transport drugs?. J. Membr. Biol. 166, 71-73.
131. 131. Roepe, P.D. (1995) The role of the MDR protein in altered drug translocation across tumor cell membranes. Biochim. Biophys. Acta 1241, 385-405.
132. 132. Fritz, F., Howard, E.M., Hoffman, M.M. & Roepe, P.D. (1999) Evidence for altered ion transport in Saccharomyces cerevisiae overexpressing human MDR 1 protein. Biochemistry 38, 4214-4226.
133. 133. Gottesman, M.M. & Pastan, I. (1993) Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem. 62, 385-427.
134. 134. Bolhuis, H., van Veen, H.W., Molenaar, D., Poolman, B., Driessen, A.J.M. & Konings, W.N. (1996) Multidrug resistance in Lactococcus lactis: evidence for ATP-dependent drug extrusion from the inner leaflet of the cytoplasmic membrane. EMBO J. 15, 4239-4245.
135. 135. Higgins, C.F. & Gottesman, M.M. (1992) Is the multidrug transporter a flippase? Trends Pharmacol. Sci. 17, 18-21.
136. 136. Ruetz, S. & Gros, P. (1994) Phosphatidylcholine translocase: a physiological role for the mdr2 gene. Cell 77, 1071-1081.
137. 137. van Helvoort, A., Smith, A.J., Sprong, H., Fritzsche, I., Schinkel, A.H., Borst, P. & van Meer, G. (1996) MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine. Cell 87, 507-517.
138. 138. Stein, W.D. (1997) Kinetics of the multidrug transporter (P-glycoprotein) and its reversal. Physiol. Rev. 77, 545-590.
139. 139. Rosenberg, M.F., Callaghan, R., Ford, R.C. & Higgins, C.F. (1997) Structure of the multidrug resistance P-glycoprotein to 2.5 nm resolution determined by electron microscopy and image analysis. J. Biol. Chem. 272, 10685-10694.
140. 140. Hanna, B., Brault, M., Kwan, T., Kast, C. & Gros, P. (1996) Mutagenesis of transmembrane domain 11 of P-glycoprotein by alanine scanning. Biochemistry 35, 3625-3635.
141. 141. Saier, M.H. Jr, Paulsen, I.T., Sliwinski, M.K., Pao, S.S., Skurray, R.A. & Nikaido, H. (1998) Evolutionary origins of multidrug and drug-specific efflux pumps in bacteria. FASEB J. 12, 265-274.
142. 142. Martoglio, B., Hofmann, M.W., Brunner, J. & Dobberstein, B. (1995) The protein-conducting channel in the membrane of the endoplasmic reticulum is open laterally toward the lipid bilayer. Cell 81, 207-214.
143. 143. Juliano, R.L. & Ling, V. (1976) A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim. Biophys. Acta 455, 152-154.
144. 144. Alon, N., Busche, R., Tümmler, B. & Riordan, J.R. (1991) Membrane lipids of multidrug-resistant cells: chemical composition and physical state. In Molecular and Cellular Biology of Multidrug Resistance in Tumor Cells (Roninson, I., ed.), pp. 263-276, Plenum Press, New York.
145. 145. Ramu, A., Glaubinger, D. & Weintraub, H. (1984) Differences in lipid composition of doxorubicin-sensitive and doxorubicin-resistant P388 cells. Cancer Treat. Report 68, 637-641.
146. 146. Tapiero, H., Mishal, Z., Wioland, M., Silber, A., Fourcade, A. & Zwingelstein, G. (1986) Changes in biophysical parameters and in phospholipid composition associated with resistance to doxorubicin. Anticancer Res. 6, 649-652.
147. 147. Wright, L.C., Dyne, M., Holmes, K.T. & Mountford, C.E. (1985) Phospholipid and ether linked phospholipid content alter with cellular resistance to vinblastine. Biochim. Biophys. Res. Com. 133, 539-545.
148. 148. Wilder, P.J., Overman, D.K., Tenenholz, T.C. & Gutierrez, P.L. (1990) Differences in myristic acid synthesis and in metabolic rate for P388 cells resistant to doxorubicin. J. Lipid Res. 31, 1973-1982.
149. 149. Mazzoni, A. & Trave, F. (1993) Cytoplasmic membrane cholesterol and doxorubicin cytotoxicity in drug-sensitive and multidrug-resistant human ovarian cancer cells. Oncol. Res. 5, 75-82.
150. 150. Pallarés-Trujillo, J., Domènech, C., Grau-Oliete, M.R. & Rivera-Fillat, M.P. (1993) Role of cell cholesterol in modulating vincristine uptake and resistance. Int. J. Cancer 55, 667-671.
151. 151. Vrignaud, P. & Robert, J. (1987) Free fatty acid uptake is increased in doxorubicin-resistant rat glioblastoma cells. Biochim. Biophys. Acta 902, 149-153.
152. 152. Boscoboinik, D. & Epand, R.M. (1989) Increased cellular internalization of amphiphiles in a multidrug-resistant CHO cell line. Biochim. Biophys. Acta 1014, 53-56.
153. 153. Kiss, Z., Tomono, M. & Anderson, W.B. (1994) Phorbol ester selectively stimulates the phospholipase D-mediated hydrolysis of phosphatidylethanolamine in multidrug-resistant MCF-7 human breast carcinoma cells. Biochem. J. 302, 649-654.
154. 154. Lavie, Y., Cao, H.T., Bursten, S.L., Giuliano, A.E. & Cabot, M.C. (1996) Accumulation of glucosylceramides in multidrug-resistant cancer cells. J. Biol. Chem. 271, 19530-19536.
155. 155. Arsenault, A.L., Ling, V. & Kartner, N. (1988) Altered plasma membrane ultrastructure in multidrug-resistant cells. Biochim. Biophys. Acta 938, 315-321.
156. 156. García-Segura, L.M., Ferragut, J.A., Ferrier-Montiel, A.V., Escriba, P.V. & Gonzalez-Ros, J.M. (1990) Ultrastructural alterations in plasma membranes from drug-resistant P388 murine leukemia cells. Biochim. Biophys. Acta 1029, 191-195.
157. 157. Beck, W.T. (1987) The cell biology of multiple drug resistance. Biochem. Pharmacol. 36, 2879-2887.
158. 158. Sehested, M., Skovsgaard, T., van Deurs, B. & Winther-Nielsen, H. (1987) Increase in non-specific adsorptive endocytosis in anthracycline-and Vinca alkaloid-resistant Ehrlich ascites tumor cell lines. J. Natl Cancer Inst. 78, 171-179.
159. 159. Sehested, M., Skovsgaard, T., van Deurs, B. & Winther-Nielsen, H. (1987) Increased plasma membrane traffic in daunorubicin resistant P388 leukaemic cells. Effect of daunorubicin and verapamil. Br. J. Cancer 56, 747-751.
160. 160. Callaghan, R., Van Gorkom, L.C.M. & Epand, R.M. (1992) A comparison of membrane properties and composition between cell lines selected and transfected for multidrug resistance. Br. J. Cancer 66, 781-786.
161. 161. Warren, L., Jardillier, J.C. & Ordentlich, P. (1991) Secretion of lysosomal enzymes by drug-sensitive and multiple drug-resistant cells. Cancer Res. 51, 1996-2001.
162. 162. Riordan, J.R. & Ling, V. (1979) Purification of P-glycoprotein from plasma membrane vesicles of Chinese hamster ovary cell mutants with reduced colchicine permeability. J. Biol. Chem. 254, 12701-12705.
163. 163. Wheeler, C., Rader, R. & Kessel, D. (1982) Membrane alterations associated with progressive adriamycin resistance. Biochem. Pharmacol. 31, 2691-2693.
164. 164. Siegfried, J.A., Kennedy, K.A., Sartorelli, A.C. & Tritton, T.R. (1983) The role of membranes in the mechanism of action of the antineoplastic agent adriamycin. Spin-labeling studies with chronically hypoxic and drug-resistant tumor cells. J. Biol. Chem. 258, 339-343.
165. 165. Rintoul, D.A. & Center, M.S. (1984) Involvement of plasma membrane lipid structural order in adriamycin resistance in Chinese hamster lung cells. Cancer Res. 44, 4978-4980.
166. 166. Ramu, A., Glaubiger, D., Magrath, I.T. & Joshi, A. (1983) Plasma membrane lipid structural order in doxorubicin-sensitive and -resistant P388 cells. Cancer Res. 43, 5533-5537.
167. 167. Montaudon, D., Vrignaud, P., Londos-Gagliardi, D. & Robert, J. (1986) Fluorescence anisotropy of cell membranes of doxorubicin-sensitive and -resistant rodent tumoral cells. Cancer Res. 46, 5602-5605.
168. 168. Kessel, D. (1988) Probing membrane alterations associated with anthracycline resistance using fluorescent dyes. Biochem. Pharmacol. 37, 4253-4256.
169. 169. Loe, D.W. & Sharom, F.J. (1993) Interaction of multidrug-resistant Chinese hamster ovary cells with amphiphiles. Br. J. Cancer 68, 342-351.
170. 170. Pain, J., Sirotnak, F.M., Barrueco, J.R., Yang, C.H. & Biedler, J.L. (1988) Altered molecular properties of tubulin in a multidrug-resistant variant of Chinese hamster cells selected for resistance to vinca alkaloids. J. Cell Physiol. 136, 341-347.
171. 171. Hill, B.T. (1993) Differing patterns of cross-resistance resulting from exposures to specific antitumour drugs or to radiation in vitro. Cytotechnol. 12, 265-288.
172. 172. Wei, L.Y., Hoffman, M.M. & Roepe, P.D. (1997) Altered pHi regulation in 3T3/CFTR clones and their chemotherapeutic drug-selected derivatives. Am. J. Physiol. 272, C1642-C1653.
173. 173. Hoffman, M.M., Wei, L.Y. & Roepe, P.D. (1996) Are altered pHi and membrane potential in hu MDR1 transfectants sufficient to cause MDR protein-mediated multidrug resistance? J. Gen. Physiol. 108, 295-313.
174. 174. Escriba, P.V., Ferrier-Montiel, A.V., Ferragut, J.A. & Gonzalez-Ros, J.M. (1990) Role of membrane lipids in the interaction of daunomycin with plasma membrane from tumor cells: implications in drug-resistance phenomena. Biochemistry 29, 7275-7282.
175. 175. Ferrier-Montiel, A.V., Gonzalez-Ros, J.M. & Ferragut, J.A. (1992) Different distribution of daunomycin in plasma membranes from drug-sensitive and drug-resistant P388 leukemia cells. Biochim. Biophys. Acta 1104, 111-116.
176. 176. Liu, Y.Y., Han, T.Y., Giuliano, A.E. & Cabot, M.C. (1999) Expression of glucosylceramide synthase, converting ceramide to glucosylceramide, confers adriamycin resistance in human breast cancer cells. J. Biol. Chem. 274, 1140-1146.
177. 177. van den Hazel, H.B., Pichler, H., do Valle Matta, M.A., Leitner, E., Goffeau, A. & Daum, G. (1999) PDR16 and PDR17, two homologous genes of Saccharomyces cerevisiae, affect lipid biosynthesis and resistance to multiple drugs. J. Biol. Chem. 274, 1934-1941.
178. 178. Le Moyec, L., Tatoud, R., Degeorges, A., Calabresse, C., Bauza, G., Eugene, M. & Calvo, F. (1996) Proton nuclear magnetic resonance spectroscopy reveals cellular lipids involved in resistance to adriamycin and taxol by the K562 leukemia cell line. Cancer Res. 56, 3461-3467.
179. 179. Callaghan, R. & Riordan, J.R. (1995) Collateral sensitivity of multidrug resistant cells to narcotic analgesics is due to effects on the plasma membrane. Biochim. Biophys. Acta 1236, 155-162.
180. 180. Schuurhuis, G.J., van Heijningen, T.H.M., Cervantes, A., de Pinedo, H.M., Lange, J.H.M., Keizer, H.G., Broxterman, H.J., Baak, J.P.A. & Lankelma, J. (1993) Changes in subcellular doxorubicin distribution and cellular accumulation alone can largely account for doxorubicin resistance in SW-1573 lung cancer and MCF-7 breast cancer multidrug resistant tumour cells. Br. J. Cancer 68, 898-908.
181. 181. García-Segura, L.M., Soto, F., Planells-Cases, R., Gonzalez-Ros, J.M. & Ferragut, J.A. (1992) Verapamil reverses the ultrastructural alterations in the plasma membrane induced by drug resistance. FEBS Lett. 314, 404-408.
182. 182. Cano-Gauci, D.F. & Riordan, J.R. (1987) Action of calcium antagonists on multidrug resistant cells. Specific cytotoxicity independent of increased cancer drug accumulation. Biochem. Pharmacol. 36, 2115-2123.
183. 183. Twentyman, P.R. (1988) A possible role for cyclosporins in cancer chemotherapy. Anticancer Res. 8, 985-993.
184. 184. Cass, C.E., Janowska-Wieczorek, A., Lynch, M.A., Sheinin, H., Hindenburg, A.A. & Beck, W.T. (1989) Effect of duration of exposure to verapamil on vincristine activity against multidrug resistant human leukemic cell lines. Cancer Res. 49, 5798-5804.
185. 185. Horton, J.K., Thimmaiah, K.N., Harwood, F.C., Kuttesch, J.F. & Houghton, P.J. (1993) Pharmacological characterization of N-substituted phenoxazines directed toward reversing Vinca alkaloid resistance in multidrug-resistant cancer cells. Mol. Pharmacol. 44, 552-559.
186. 186. Cabot, M.C., Giuliano, A.E., Han, T.Y. & Liu, Y.Y. (1999) SDZ PSC 833, the cyclosporine A analogue and multidrug resistance modulator, activates ceramide synthesis and increases vinblastine sensitivity in drug-sensitive and drug-resistant cancer cells. Cancer Res. 59, 880-885.
187. 187. Lavie, Y., Cao, H.T., Volner, A., Lucci, A., Man, T.Y., Geffen, V., Giuliano, A.E. & Cabot, M.C. (1997) Agents that reverse multidrug resistance, tamoxifen, verapamil, and cyclosporin A, block glycosphingolipid metabolism by inhibiting ceramide glycosylation in human cancer cells. J. Biol. Chem. 272, 1682-1687.
188. 188. Ramu, A., Ramu, N. & Rosario, L.M. (1991) Circumvention of multidrug-resistance in P388 cells is associated with a rise in the cellular content of phosphatidylcholine. Biochem. Pharmacol. 41, 1455-1461.
189. 189. Wadkins, R.M. & Houghton, P.J. (1993) The role of drug-lipid interactions in the biological activity of modulators of multidrug resistance. Biochim. Biophys. Acta 1153, 225-236.
190. 190. Wiseman, H. (1994) Tamoxifen: new membrane-mediated mechanisms of action and therapeutic advances. Trends Pharmacol. Sci. 15, 83-89.
191. 191. Kiss, Z. & Crilly, K.S. (1995) Tamoxifen inhibits uptake and metabolism of ethanolamine and choline in multidrug-resistant, but not in drug-sensitive, MCF-7 human breast carcinoma cells. FEBS Lett. 360, 165-168.
192. 192. Cabot, M.C., Han, T.Y. &Giuliano, A.E. (1998) The multidrug resistance modulator SDZ PSC 833 is a potent activator of cellular ceramide formation. FEBS Lett. 431, 185-188.
193. 193. Drori, S., Eytan, G.D. & Assaraf, Y.G. (1995) Potentiation of anticancer-drug cytotoxicity by multidrug-resistance chemo-sensitizers involves alterations in membrane fluidity leading to increased membrane permeability. Eur. J. Biochem. 228, 1020-1029.
194. 194. Dudeja, P.K., Anderson, K.M., Harris, J.S., Buckingham, L. & Coon, J.S. (1995) Reversal of multidrug resistance phenotype by surfactants: relationship to membrane lipid fluidity. Arch. Biochem. Biophys. 319, 309-315.
195. 195. Jaffrézou, J.P. & Laurent, G. (1993) The intriguing link between modulation of both multidrug resistance and ligand-toxin conjugate cytotoxicity. FEBS Lett. 323, 191-197.
196. 196. Jaffrézou, J.P, Chen, G., Durán, G.E., Muller, C., Bordier, C., Laurent, G., Sikic, B.I. & Levade, T. (1995) Inhibition of lysosomal acid sphingomyelinase by agents which reverse multidrug resistance. Biochim. Biophys. Acta 1266, 1-8.
197. 197. Cabot, M.C., Giuliano, A.E., Volner, A. & Man, T.Y. (1996) Tamoxifen retards glycosphingolipid metabolism in human cancer cells. FEBS Lett. 394, 129-131.
198. 198. Sinicrope, F.A., Dudeja, P.K., Bissonnette, B.M., Safa, A.R. & Brasitus, T.A. (1992) Modulation of P-glycoprotein-mediated drug transport by alterations in lipid fluidity of rat liver canalicular membrane vesicles. J. Biol. Chem. 267, 24995-25002.
199. 199. Callaghan, R., Stafford, A. & Epand, R.M. (1993) Increased accumulation of drugs in a multidrug-resistant cell line by alteration of membrane biophysical properties. Biochim. Biophys. Acta 1175, 277-282.
200. 200. Regev, R., Assaraf, Y.G. & Eytan, G.D. (1999) Membrane fluidization by ether, other anesthetics, and certain agents abolishes P-glycoprotein ATPase activity and modulates efflux from multidrug-resistant cells. Eur. J. Biochem. 259, 18-24.
201. 201. Warren, L., Jardillier, J.C., Malarska, A. & Akeli, M.G. (1992) Increased accumulation of drugs in multidrug-resistant cells induced by liposomes. Cancer Res. 52, 3241-3245.
202. 202. Altan, N., Chen, Y., Schindler, M. & Simon, S.M. (1999) Tamoxifen inhibits acidification in cells independent of the estrogen receptor. Proc. Natl Acad. Sci. USA 96, 4432-4437.
203. 203. Speelmans, G., Staffhorst, R.W.H.M., de Wolf, F.A. & de Kruijff, B. (1995) Verapamil competes with doxorubicin for binding to anionic phospholipids resulting in enhanced internal concentrations and rates of passive transport of doxorubicin. Biochim. Biophys. Acta 1238, 137-146.
204. 204. Kast, C., Canfield, V., Levenson, R. & Gros, P. (1996) Transmembrane organization of mouse P-glycoprotein determined by epitope insertion and immunofluorescence. J. Biol. Chem. 271, 9240-9248.
205. 205. Zhang, M., Wang, G., Shapiro, A. & Zhang, J.T. (1996) Topological folding and proteolysis profile of P-glycoprotein in membranes of multidrug-resistant cells: implications for the drug transport mechanism. Biochemistry 35, 9728-9736.
206. 206. Economou, A. & Wickner, W. (1994) SecA promotes preprotein translocation by undergoing ATP-driven cycles of membrane insertion and deinsertion. Cell 78, 835-843.
207. 207. Jones, P.M. & George, A.M. (1998) A new structural model for P-glycoprotein. J. Membr. Biol. 166, 133-147.
208. 208. Liu, R. & Sharom, F.J. (1998) Proximity of the nucleotide binding domains of P-glycoprotein multidrug transporter to the membrane surface: a resonance energy transfer study. Biochemistry 37, 6503-6512.
209. 209. Ko, Y.H., Delannoy, M. & Pedersen, P.L. (1997) Cystic fibrosis transmembrane conductance regulator: the first nucleotide binding fold targets the membrane with retention of its ATP binding function. Biochemistry 36, 5053-5064.
210. 210. Kerppola, R.E., Shyamala, V.K., Klebba, P. & Ames, G.F. (1991) The membrane-bound proteins of periplasmic permeases form a complex. Identification of the histidine permease HisQMP complex. J. Biol. Chem. 266, 9857-9865.
211. 211. Riehm, H. & Biedler, J.L. (1972) Potentiation of drug effect by Tween 80 in Chinese hamster cells resistant to actinomycin D and daunomycin. Cancer Res. 32, 1195-1200.
212. 212. Ramu, A. & Ramu, N. (1993) Resistance to lipophilic cationic compounds in multidrug resistant leukemia cells. Leuk. Lymphoma 9, 247-253.
213. 213. Dellinger, M., Pressman, B.C., Calderon-Higginson, C., Savaraj, N., Tapiero, H., Kolonias, D. & Lampidis, T.J. (1992) Structural requirements of simple organic cations for recognition by multi-drug-resistant cells. Cancer Res. 52, 6385-6389.
214. 214. Woodcock, D.M., Linsenmeyer, M.E., Chojnowski, G., Kriegler, A.B., Nink, V., Webster, L.K. & Sawyer, W.H. (1992) Reversal of multidrug resistance by surfactants. Br. J. Cancer 66, 62-68.
215. 215. Zordan-Nudo, T., Ling, V., Liu, Z. & Georges, E. (1993) Effects of nonionic detergents on P-glycoprotein drug binding and reversal of multidrug resistance. Cancer Res. 53, 5994-6000.
216. 216. Coon, J.S., Knudson, W., Clodfelter, K., Lu, B. & Weinstein, R.S. (1991) Solutol HS 15, nontoxic polyoxyethylene esters of 12-hydroxystearic acid, reverses multidrug resistance. Cancer Res. 51, 897-902.
217. 217. Callaghan, R., Berridge, G., Ferry, D.R. & Higgins, C.F. (1997) The functional purification of P-glycoprotein is dependent on maintenance of a lipid-protein interface. Biochim. Biophys. Acta 1328, 109-124.
218. 218. Orlowski, S., Selosse, M.A., Boudon, C., Micoud, C., Mir, L.M., Belehradek, J. Jr & Garrigos, M. (1998) Effects of detergents on P-glycoprotein ATPase activity: differences in perturbations of basal and verapamil-dependent activities. Cancer Biochem. Biophys. 16, 85-110.
219. 219. Doige, C.A., Yu, X. & Sharom, F.J. (1993) The effects of lipids and detergents on ATPase-active P-glycoprotein. Biochim. Biophys. Acta 1146, 65-72.
220. 220. Sharom, F.J., Yu, X., Chu, J.W. & Doige, C.A. (1995) Characterization of the ATPase activity of P-glycoprotein from multidrug-resistant Chinese hamster ovary cells. Biochem. J. 308, 381-390.
221. 221. Putman, M., van Veen, H.W., Poolman, B. & Konings, W.N. (1999) Restrictive use of detergents in the functional reconstitution of the secondary multidrug transporter LmrP. Biochemistry 38, 1002-1008.
222. 222. Urbatsch, I.L. & Senior, A.E. (1995) Effects of lipid on ATPase activity of purified Chinese hamster P-glycoprotein. Arch. Biochem. Biophys. 316, 135-140.
223. 223. Sharom, F.J. (1997) The P-glycoprotein multidrug transporter: interactions with membrane lipids, and their modulation of activity. Biochem. Soc. Trans. 25, 1088-1096.
224. 224. Romsicki, Y. & Sharom, F.J. (1998) The ATPase and ATP-binding functions of P-glycoprotein. Modulation by interaction with defined phospholipids. Eur. J. Biochem. 256, 170-178.
225. 225. Yeagle, P.L. (1991) Modulation of membrane function by cholesterol. Biochimie 73, 1303-1310.
226. 226. Addona, G.H., Sandermann, H. Jr, Kloczewiak, M.A., Husain, S.S. & Miller, K.W. (1998) Where does cholesterol act during activation of the nicotinic acetylcholine receptor? Biochim. Biophys. Acta 1370, 299-309.
227. 227. Saeki, T., Shimabuku, A.M., Ueda, K. & Komano, T. (1992) Specific drug binding by purified lipid-reconstituted P-glycoprotein: dependence on the lipid composition. Biochim. Biophys. Acta 1107, 105-110.
228. 228. Krishnamurthy, S.S. & Prasad, R. (1999) Membrane fluidity affects functions of Cdr1p, a multidrug ABC transporter of Candida albicans. FEMS Microbiol. Lett. 173, 475-481.
229. 229. Kaur, R. & Bachhawat, A.K. (1999) The yeast multidrug resistance pump, Pdr5p, confers reduced drug resistance in erg mutants of Saccharomyces cerevisiae. Microbiol. 145, 809-818.
230. 230. Romsicki, Y. & Sharom, F.J. (1997) Interaction of P-glycoprotein with defined phospholipid bilayers: a differential scanning calorimetric study. Biochemistry 36, 9807-9815.
231. 231. Bosch, I., Dunussi-Joannopoulos, K., Wu, R.L., Furlong, S.T. & Croop, J. (1997) Phosphatidylcholine and phosphatidylethanolamine behave as substrates of the human MDR1 P-glycoprotein. Biochemistry 36, 5685-5694.
232. 232. van Helvoort, A., Giudici, M.L., Thielemans, M. & van Meer, G. (1997) Transport of sphingomyelin to the cell surface is inhibited by brefeldin A and in mitosis where C6-NBD-sphingomyelin is translocated across the plasma membrane by a multidrug transporter activity. J. Cell Sci. 110, 75-83.
233. 233. Dekkers, D.W., Comfurius, P., Schroit, A.J., Bevers, E.M. & Zwaal, R.F. (1998) Transbilayer movement of NBD-labeled phospholipids in red blood cell membranes: outward-directed transport by the multidrug resistance Protein 1 (MRP1). Biochemistry 37, 14833-14837.
234. 234. Raggers, R.J., van Helvoort, A., Evers, R. & van Meer, G. (1999) The human multidrug resistance protein MRP1 translocates sphingolipid analogs across the plasma membrane. J. Cell Sci. 112, 415-422.
235. 235. Decottignies, A., Grant, A.M., Nichols, J.W., de Wet, H., McIntosh, D.B. & Goffeau, A. (1998) ATPase and multidrug transport activities of the overexpressed yeast ABC protein Yor1p. J. Biol. Chem. 273, 12612-12622.
236. 236. Dogra, S., Krishnamurthy, S., Gupta, V., Dixit, B.L., Gupta, C.M., Sanglard, D. & Prasad, R. (1999) Asymmetric distribution of phosphatidylethanolamine in C. albicans: Possible mediation by CDR1, a multidrug transporter belonging to ATP Binding Cassette (ABC) superfamily. Yeast 15, 111-122.
237. 237. Ortwein, R., Oslender-Kohnen, A. & Deuticke, B. (1994) Band 3, the anion exchanger of the erythrocyte membrane, is also a flippase. Biochim. Biophys. Acta 1191, 317-323.
238. 238. Lange, Y. & Steck, T.L. (1994) Cholesterol homeostasis. Modulation by amphiphiles. J. Biol. Chem. 269, 29371-29374.
239. 239. Field, F.J., Born, E., Chen, H., Murthy, S. & Mathur, S.N. (1995) Esterification of plasma membrane cholesterol and triacylglycerol-rich lipoprotein secretion in CaCo-2 cells: possible role of P-glycoprotein. J. Lipid Res. 36, 1533-1543.
240. 240. Metherall, J.E., Li, H. & Waugh, K. (1996) Role of multidrug resistance P-glycoproteins in cholesterol biosynthesis. J. Biol. Chem. 271, 2634-2640.
241. 241. Debry, P., Nash, E.A., Neklason, D.W. & Metherall, J.E. (1997) Role of multidrug resistance P-glycoproteins in cholesterol esterification. J. Biol. Chem. 272, 1026-1031.
242. 242. Altuvia, S., Stein, W.D., Goldenberg, S., Kane, S.E., Pastan, I. & Gottesman, M.M. (1993) Targeted disruption of the mouse mdr1b gene reveals that steroid hormones enhance mdr gene expression. J. Biol. Chem. 268, 27127-27132.
243. 243. Peterson, R.H.F., Meyers, M.B., Spengler, B.A. & Biedler, J.L. (1983) Alteration of plasma membrane, glycoproteins and gangliosides of Chinese hamster ovary cells accompanying development of resistance to daunorubicin and vincristine. Cancer Res. 43, 222-228.
244. 244. Fukumoto, H., Nishio, K., Ohta, S., Hanai, N. & Saijo, N. (1996) Reversal of adriamycin resistance with chimeric anti-ganglioside G (M2) antibody. Int. J. Cancer 67, 676-680.
245. 245. Bezombes, C., Maestre, N., Laurent, G., Levade, T., Bettaieb, A. & Jaffrézou, J.P. (1998) Restoration of TNF-alpha-induced ceramide generation and apoptosis in resistant human leukemia KG1A cells by the P-glycoprotein blocker PSC 833. FASEB J. 12, 101-109.
246. 246. Simons, K. & Ikonen, E. (1997) Functional rafts in cell membranes. Nature 387, 569-572.
247. 247. Jacobson, K. & Dietrich, C. (1999) Looking at lipid rafts? Trends Cell Biol. 9, 87-91.
248. 248. Lavie, Y., Fiucci, G. & Liscovitch, M. (1998) Up-regulation of caveolae and caveolar constituents in multidrug-resistant cancer cells. J. Biol. Chem. 273, 32380-32383.
249. 249. Testi, R. (1996) Sphingomyelin breakdown and cell fate. Trends Biochem. Sci. 21, 468-471.
250. 250. Biedler, J.L. & Spengler, B.A. (1994) Genetics of drug resistance. In Anticancer Drug Resistance: Advances in Molecular and Clinical Research (Goldstein, L.J., Ozols, R.F., eds), pp. 1-16, Kluwer Academic, Dordrecht.
251. 251. Takanishi, K., Miyazaki, M., Ohtsuka, M. & Nakajima, N. (1997) Inverse relationship between P-glycoprotein expression and its proliferative activity in hepatocellular carcinoma. Oncology 54, 231-237.
252. 252. Takeshita, H., Kusuzaki, K., Ashihara, T., Gebhardt, M.C., Mankin, H.J. & Hirasawa, Y. (1998) Actin organization associated with the expression of multidrug resistant phenotype in osteosarcoma cells and the effect of actin depolymerization on drug resistance. Cancer Lett. 126, 75-81.
253. 253. Altan, N., Chen, Y., Schindler, M. & Simon, S.M. (1998) Defective acidification in human breast tumor cells and implication for chemotherapy. J. Exp. Med. 187, 1583-1598.
254. 254. Robinson, L.J., Roberts, W.K., Ling, T.T., Lamming, D., Sternberg, S.S. & Roepe, P.D. (1997) Human MDR1 overexpression delays the apoptotic cascade in Chinese hamster ovary fibroblasts. Biochemistry 36, 11169-11178.
255. 255. Johnstone, R.W., Cretney, E. & Smyth, M.J. (1999) P-glycoprotein protects leukemia cells against caspase-dependent, but not caspase-independent, cell death. Blood 93, 1075-1085.
256. 256. Divecha, N. & Irvine, R.F. (1995) Phospholipid signaling. Cell 80, 269-278.
257. 257. Higgins, C.F. (1995) The ABC of channel regulation. Cell 82, 693-696.
258. 258. Weiss, S. (1999) Fluorescence spectroscopy of single biomolecules. Science 283, 1676-1683.